Bruxelles Woluwe

Selected publications

- Marie-Paule Mingeot-Leclercq -

  1. El Khoury M., G. Sautrey, L. Zimmermann, P. Van Der Smissen, J.-L. Décout, and Mingeot-Leclercq M-P.
    Targeting Bacterial Cardiolipin Enriched Microdomains: A New Promising Antimicrobial Strategy?
    Sci.Reports (2017), 7:10697.  
  2. Mingeot-Leclercq M-P., Deleu M, Brasseur R, Dufrêne YF.
    Atomic force microscopy of supported lipid bilayers.
    Nat Protoc. (2008), 3: 1654-1659.
  3. Mingeot-Leclercq M-P., Tulkens PM.
    Aminoglycosides: nephrotoxicity.
    Antimicrob Agents Chemother. (1999), 43:1003-1012.
  4. Sautrey G., M. El Khoury, A. Dos Giros L. Zimmermann, M. Deleu, L. Lins, J.-L Decout and Mingeot-Leclercq M.-P.
    Negatively-Charged Lipids as Potential Target for New Amphiphilic Aminoglycoside Antibiotics: a biophysical study.
    J. Biol. Chem. (2016), 291: 13864-13874.
  5. Verstraeten S.L., Deleu M., Janikowska-Sagan M., Claereboudt E.J.S., Lins L., Tyteca D., Mingeot-Leclercq M.-P.
    The activity of the saponin ginsenoside Rh2 is enhanced by the interaction with membrane sphingomyelin but depressed by cholesterol
    Sc Rep. (2019), 9: 7285

- Françoise Van Bambeke -

  1. Chalhoub H., Pletzer D., Weingart H., Braun Y., Tunney M.M., Elborn J.S., Rodriguez-Villalobos H., Plésiat P., Kahl B.C., Denis O., Winterhalter M., Tulkens P.M., Van Bambeke F.
    Mechanisms of intrinsic resistance and acquired susceptibility of Pseudomonas aeruginosa isolated from cystic fibrosis patients to temocillin, a revived antibiotic.
    Scientific Reports (2017) 7:40208
  2. Chalhoub H., Harding S.V., Tulkens P.M., Van Bambeke F.
    Influence of pH on the activity of finafloxacin against extracellular and intracellular Burkholderia thailandensis, Yersinia pseudotuberculosis and Francisella philomiragia and on its cellular pharmacokinetics in THP-1 monocytes.
    In: Clin Microbiol Infect. (2019) Aug 9.
  3. Miranda-Bastos A.C., Vandecasteele S.J., Spinewine A., Tulkens P.M., Van Bambeke F.
    Temocillin dosing in haemodialysis patients based on population pharmacokinetics of total and unbound concentrations and Monte Carlo simulation.
    In: Journal of Antimicrobial Chemotherapy (2018) 73: 1630-1638
  4. Siala W., Kucharíková S., Braem A., Vleugels J., Tulkens P.M., MingeotLeclercq M-P., Van Dijck P., Van Bambeke F.
    The antifungal caspofungin increases fluoroquinolone activity against Staphylococcus aureus biofilms by inhibiting N-acetylglucosamine transferase.
    Nature Communications (2016) 7:13286
  5. Mustafa M-H., Khandekar S., Tunney M.M., Elborn J.S., Kahl B.C., Denis O., Plésiat P., Traore H., Tulkens P.M., Vanderbist F., Van Bambeke F.
    Acquired resistance to macrolides in Pseudomonas aeruginosa from cystic fibrosis patients.
    European Respiratory Journal (2017) 49:1601847
full list